vs
null(SWIM)与Tarsus Pharmaceuticals, Inc.(TARS)财务数据对比。点击上方公司名可切换其他公司
Tarsus Pharmaceuticals, Inc.的季度营收约是null的1.5倍($151.7M vs $100.0M),Tarsus Pharmaceuticals, Inc.净利率更高(-5.5% vs -7.0%,领先1.5%),Tarsus Pharmaceuticals, Inc.同比增速更快(128.4% vs 14.5%),null自由现金流更多($14.1M vs $13.0M),过去两年Tarsus Pharmaceuticals, Inc.的营收复合增速更高(134.4% vs -4.9%)
该企业是一家源自美国的跨国律师事务所,1934年创立于加利福尼亚州洛杉矶,在诉讼业务、公司法务以及监管合规法律领域拥有深厚的行业积累与知名度,是全球颇具影响力的综合性律所之一。
Tarsus Pharmaceuticals是一家处于后期临床阶段的生物制药公司,专注于眼科、皮肤科等专科领域创新疗法的研发和商业化,主打产品针对蠕形螨睑缘炎、玫瑰痤疮等未被充分诊断的常见病症,核心市场为美国。
SWIM vs TARS — 直观对比
营收规模更大
TARS
是对方的1.5倍
$100.0M
营收增速更快
TARS
高出113.9%
14.5%
净利率更高
TARS
高出1.5%
-7.0%
自由现金流更多
SWIM
多$1.1M
$13.0M
两年增速更快
TARS
近两年复合增速
-4.9%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | ||
|---|---|---|
| 营收 | $100.0M | $151.7M |
| 净利润 | $-7.0M | $-8.4M |
| 毛利率 | 28.0% | — |
| 营业利润率 | -10.7% | -5.3% |
| 净利率 | -7.0% | -5.5% |
| 营收同比 | 14.5% | 128.4% |
| 净利润同比 | 76.0% | 63.8% |
| 每股收益(稀释后) | $-0.06 | $-0.17 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
SWIM
TARS
| Q4 25 | $100.0M | $151.7M | ||
| Q3 25 | $161.9M | $118.7M | ||
| Q2 25 | $172.6M | $102.7M | ||
| Q1 25 | $111.4M | $78.3M | ||
| Q4 24 | $87.3M | $66.4M | ||
| Q3 24 | $150.5M | $48.1M | ||
| Q2 24 | $160.1M | $40.8M | ||
| Q1 24 | $110.6M | $27.6M |
净利润
SWIM
TARS
| Q4 25 | $-7.0M | $-8.4M | ||
| Q3 25 | $8.1M | $-12.6M | ||
| Q2 25 | $16.0M | $-20.3M | ||
| Q1 25 | $-6.0M | $-25.1M | ||
| Q4 24 | $-29.2M | $-23.1M | ||
| Q3 24 | $5.9M | $-23.4M | ||
| Q2 24 | $13.3M | $-33.3M | ||
| Q1 24 | $-7.9M | $-35.7M |
毛利率
SWIM
TARS
| Q4 25 | 28.0% | — | ||
| Q3 25 | 35.4% | — | ||
| Q2 25 | 37.1% | — | ||
| Q1 25 | 29.5% | — | ||
| Q4 24 | 24.6% | — | ||
| Q3 24 | 32.4% | — | ||
| Q2 24 | 33.1% | — | ||
| Q1 24 | 27.7% | — |
营业利润率
SWIM
TARS
| Q4 25 | -10.7% | -5.3% | ||
| Q3 25 | 13.3% | -12.2% | ||
| Q2 25 | 14.3% | -21.6% | ||
| Q1 25 | -4.4% | -33.5% | ||
| Q4 24 | -14.9% | -36.8% | ||
| Q3 24 | 8.9% | -52.3% | ||
| Q2 24 | 12.5% | -81.6% | ||
| Q1 24 | -1.9% | -136.5% |
净利率
SWIM
TARS
| Q4 25 | -7.0% | -5.5% | ||
| Q3 25 | 5.0% | -10.6% | ||
| Q2 25 | 9.3% | -19.8% | ||
| Q1 25 | -5.4% | -32.1% | ||
| Q4 24 | -33.4% | -34.8% | ||
| Q3 24 | 3.9% | -48.7% | ||
| Q2 24 | 8.3% | -81.6% | ||
| Q1 24 | -7.1% | -129.4% |
每股收益(稀释后)
SWIM
TARS
| Q4 25 | $-0.06 | $-0.17 | ||
| Q3 25 | $0.07 | $-0.30 | ||
| Q2 25 | $0.13 | $-0.48 | ||
| Q1 25 | $-0.05 | $-0.64 | ||
| Q4 24 | $-0.24 | $-0.57 | ||
| Q3 24 | $0.05 | $-0.61 | ||
| Q2 24 | $0.11 | $-0.88 | ||
| Q1 24 | $-0.07 | $-1.01 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | — | $417.3M |
| 总债务越低越好 | $279.8M | $72.4M |
| 股东权益账面价值 | $405.9M | $343.4M |
| 总资产 | $823.2M | $562.2M |
| 负债/权益比越低杠杆越低 | 0.69× | 0.21× |
8季度趋势,按日历期对齐
现金及短期投资
SWIM
TARS
| Q4 25 | — | $417.3M | ||
| Q3 25 | — | $401.8M | ||
| Q2 25 | — | $381.1M | ||
| Q1 25 | — | $407.9M | ||
| Q4 24 | — | $291.4M | ||
| Q3 24 | — | $317.0M | ||
| Q2 24 | — | $323.6M | ||
| Q1 24 | — | $298.5M |
总债务
SWIM
TARS
| Q4 25 | $279.8M | $72.4M | ||
| Q3 25 | $281.1M | $72.3M | ||
| Q2 25 | $281.5M | $72.1M | ||
| Q1 25 | $306.9M | $72.0M | ||
| Q4 24 | $281.5M | $71.8M | ||
| Q3 24 | $282.8M | $71.7M | ||
| Q2 24 | $282.4M | $71.6M | ||
| Q1 24 | $282.8M | $29.9M |
股东权益
SWIM
TARS
| Q4 25 | $405.9M | $343.4M | ||
| Q3 25 | $408.4M | $335.1M | ||
| Q2 25 | $398.4M | $332.6M | ||
| Q1 25 | $381.1M | $342.5M | ||
| Q4 24 | $387.2M | $224.5M | ||
| Q3 24 | $416.6M | $237.5M | ||
| Q2 24 | $408.1M | $252.2M | ||
| Q1 24 | $391.8M | $275.2M |
总资产
SWIM
TARS
| Q4 25 | $823.2M | $562.2M | ||
| Q3 25 | $844.4M | $534.6M | ||
| Q2 25 | $822.1M | $495.0M | ||
| Q1 25 | $824.6M | $500.8M | ||
| Q4 24 | $794.2M | $377.0M | ||
| Q3 24 | $853.4M | $376.3M | ||
| Q2 24 | $830.0M | $376.8M | ||
| Q1 24 | $808.6M | $349.3M |
负债/权益比
SWIM
TARS
| Q4 25 | 0.69× | 0.21× | ||
| Q3 25 | 0.69× | 0.22× | ||
| Q2 25 | 0.71× | 0.22× | ||
| Q1 25 | 0.81× | 0.21× | ||
| Q4 24 | 0.73× | 0.32× | ||
| Q3 24 | 0.68× | 0.30× | ||
| Q2 24 | 0.69× | 0.28× | ||
| Q1 24 | 0.72× | 0.11× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $23.3M | $19.3M |
| 自由现金流经营现金流 - 资本支出 | $14.1M | $13.0M |
| 自由现金流率自由现金流/营收 | 14.1% | 8.6% |
| 资本支出强度资本支出/营收 | 9.2% | 4.2% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $38.0M | $-22.3M |
8季度趋势,按日历期对齐
经营现金流
SWIM
TARS
| Q4 25 | $23.3M | $19.3M | ||
| Q3 25 | $51.0M | $18.3M | ||
| Q2 25 | $36.0M | $-29.4M | ||
| Q1 25 | $-46.9M | $-20.7M | ||
| Q4 24 | $6.2M | $-22.2M | ||
| Q3 24 | $37.2M | $-8.7M | ||
| Q2 24 | $52.4M | $-14.4M | ||
| Q1 24 | $-34.5M | $-37.8M |
自由现金流
SWIM
TARS
| Q4 25 | $14.1M | $13.0M | ||
| Q3 25 | $45.2M | $16.3M | ||
| Q2 25 | $29.1M | $-30.4M | ||
| Q1 25 | $-50.3M | $-21.2M | ||
| Q4 24 | $-98.0K | $-22.3M | ||
| Q3 24 | $33.2M | $-8.9M | ||
| Q2 24 | $47.9M | $-15.4M | ||
| Q1 24 | $-39.9M | $-38.0M |
自由现金流率
SWIM
TARS
| Q4 25 | 14.1% | 8.6% | ||
| Q3 25 | 27.9% | 13.8% | ||
| Q2 25 | 16.8% | -29.6% | ||
| Q1 25 | -45.2% | -27.1% | ||
| Q4 24 | -0.1% | -33.5% | ||
| Q3 24 | 22.1% | -18.6% | ||
| Q2 24 | 29.9% | -37.8% | ||
| Q1 24 | -36.0% | -137.5% |
资本支出强度
SWIM
TARS
| Q4 25 | 9.2% | 4.2% | ||
| Q3 25 | 3.6% | 1.6% | ||
| Q2 25 | 4.0% | 1.0% | ||
| Q1 25 | 3.1% | 0.8% | ||
| Q4 24 | 7.2% | 0.1% | ||
| Q3 24 | 2.7% | 0.6% | ||
| Q2 24 | 2.8% | 2.5% | ||
| Q1 24 | 4.8% | 0.6% |
现金转化率
SWIM
TARS
| Q4 25 | — | — | ||
| Q3 25 | 6.29× | — | ||
| Q2 25 | 2.25× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 6.32× | — | ||
| Q2 24 | 3.95× | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
SWIM
| In Ground Swimming Pools | $50.2M | 50% |
| Covers | $37.0M | 37% |
| Liners | $12.7M | 13% |
TARS
暂无分部数据